| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC0367 |
| Trial ID | NCT03103971 |
| Disease | Acute Lymphoblastic Leukemia | B-Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | JCAR021 |
| Phase | Phase1 |
| Recruitment status | Active, Not Recruiting |
| Title | HuJCAR014 CAR-T Cells in Treating Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia |
| Year | 2017 |
| Country | United States |
| Company sponsor | Fred Hutchinson Cancer Center |
| Other ID(s) | 9364|NCI-2017-00421|9364|RG9217000 |
| Cohort 1 | |||||||||||||||||
|
|||||||||||||||||